When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
The CDC on Friday is scrubbing a swath of HIV-related content from the agency’s website as a part of Trump’s broader effort ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
"In the context of the outbreak in parts of Africa, we expect to see the occasional imported case of clade Ib mpox in the UK, ...
The Food and Drug Administration (FDA) would like you to check if you have any broccoli in your freezer, as it may be part of ...
The eminent and renowned personality Robert F. Kennedy Jr. is reportedly facing some intense and severe scrutiny while his recent confirmation hearings is going on regarding his position of US Health ...